StockTipsArenaBeta

BUY Nephrocare Health Services Limited — ICICI Securities

BUYNephrocare Health Services Limited

byICICI SecuritiesHorizon: NA (inferred 1 year)8 Sept 2026via Moneycontrol Broker Research

Entry₹716Inferred
Target₹825
Total upside +15.22%
Stop lossNot given
CMP₹736.65Just now
Active+2.88%+11.99%upside left 12 mo left
Follow ICICI Securities for new calls(68% target hit, 1028 closed calls)Get alertsWatch NEPHROPLUS for new buy/sell callsGet alertsSee 2 other Long-term calls on NEPHROPLUSSee 101 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Sept, 11:35 am IST
12 supporting2 neutral1 opposing
Supports the BUY call (12)

Nephrocare Health Services Limited is acquiring a 100% participatory interest in Dialysis Center Almaty LLP, Kazakhstan. This expansion into a new international market is likely to be significant for

NSE · Agreements·1 Sept · 1w ago

(opens in new tab)

Nephrocare Health Services Ltd's overseas subsidiary, Nephroplus Health Services Kazakhstan LLP, has entered into a Share Purchase Agreement to acquire a 100% participatory interest in Dialysis Center

BSE · Company Update·1 Sept · 1w ago

(opens in new tab)

Nephrocare Health Services Limited's Philippines subsidiary acquired assets of a dialysis center in Leyte, Philippines, for PhP 75,000,000 via an Asset Transfer Agreement.

NSE · Agreements·17 Aug · 3w ago

(opens in new tab)

Nephrocare Health Services, Philippines Inc., a step-down subsidiary, has acquired a dialysis facility.

BSE · Company Update·17 Aug · 3w ago

(opens in new tab)

Nephrocare Health Services' wholly-owned subsidiary in Philippines has acquired assets of a dialysis center in Davao City for PhP 71,800,000.

BSE · Company Update·13 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (2)

The Board of Directors met on August 11, 2026, and approved the unaudited financial results for the quarter ended June 30, 2026. The meeting also included the reconstitution of the Audit Committee and

BSE · Others·11 Aug · 4w ago

(opens in new tab)

Nephrocare Health Services Limited announced its unaudited financial results for the quarter ended June 30, 2026. The board meeting also approved the reconstitution of the Audit Committee and the Stak

NSE · Outcome of Board Meeting·11 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Nephrocare Health Services Limited has informed the exchange about a tax demand arising from a tax audit. This indicates a potential financial liability for the company.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·31 Aug · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.